Exploring the Role of MicroRNAs in Cancer Progression and Therapeutic Development

Thesis Abstract

Abstract
MicroRNAs (miRNAs) are small non-coding RNA molecules that play crucial roles in the regulation of gene expression at the post-transcriptional level. In the context of cancer, dysregulation of miRNAs has been implicated in various aspects of tumorigenesis, including cancer progression and response to therapy. This thesis aims to explore the role of miRNAs in cancer progression and therapeutic development, focusing on their potential as diagnostic biomarkers and therapeutic targets. Chapter 1 provides an introduction to the field of miRNA research, highlighting the importance of understanding the molecular mechanisms underlying cancer progression. The background of the study discusses the current knowledge regarding miRNAs and their involvement in cancer biology. The problem statement addresses the need to further investigate the specific roles of miRNAs in different types of cancer. The objectives of the study outline the specific goals and research questions that will be addressed. Limitations of the study and the scope of the research are also discussed, along with the significance of the study in advancing our understanding of cancer biology. Finally, the structure of the thesis and key definitions of terms are provided to guide the reader through the document. Chapter 2 presents a comprehensive literature review of existing studies on miRNAs in cancer progression and therapeutic development. Ten key areas of focus are identified, including the role of specific miRNAs in different cancer types, their impact on tumor growth and metastasis, and their potential as predictive biomarkers for treatment response. Chapter 3 details the research methodology employed in this study, including sample collection, miRNA profiling techniques, bioinformatics analysis, and statistical methods. Eight key components are discussed, such as the selection criteria for patient samples, experimental design, data analysis pipelines, and validation strategies for miRNA targets. Chapter 4 presents a detailed discussion of the findings obtained from the research, including the identification of dysregulated miRNAs in cancer samples, their putative target genes, and functional implications in cancer progression. The results are contextualized within the existing literature to provide a comprehensive understanding of the role of miRNAs in cancer biology. Chapter 5 serves as the conclusion and summary of the thesis, highlighting the key findings, implications for cancer research and therapy, and potential future directions. Overall, this study contributes to the growing body of knowledge on miRNAs in cancer and provides valuable insights into their potential clinical applications. In conclusion, this thesis sheds light on the role of miRNAs in cancer progression and therapeutic development, emphasizing their significance as key regulators of gene expression in cancer biology. The findings presented here have implications for the development of novel diagnostic tools and targeted therapies for cancer patients, paving the way for personalized medicine approaches in oncology.